Request Trial
shutterstock-185473370
JacobSt / Shutterstock.com
29 October 2014AsiaSwarup Kumar and Shivaarti Bajaj

Challenges to the patenting of “essentially biological processes” in India

Commenting on the US Supreme Court’s historic decision Diamond v Chakrabarty, 447 US 303 (1980), which permitted the patenting of life forms, Justice Warren Burger said: “No one will be able to deter the scientific mind from probing into the unknown any more than Canute could command the tides”. Probing into the unknown and the possibility of patenting one’s invention is what has catalysed scientific advancement in all fields of technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Takeda’s China IP head: What pharma is still getting wrong
27 May 2026   China’s IP system is undergoing real change. Takeda’s IP head for the region explains what that looks like on the ground and why the old playbook no longer cuts it.
Asia
Healthcare leads sweeping AI partnership in Singapore
20 May 2026   Backed by the country’s wider AI ambitions, Google has signed a deal to roll out healthcare, scientific research, and safety initiatives.
Asia
IndiaMart v CDSCO: A test of intermediary liability
31 March 2026   The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.


Editor's picks

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

Editor's picks

Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026

More features

Takeda’s China IP head: What pharma is still getting wrong
Healthcare leads sweeping AI partnership in Singapore
BMS signs $15.2bn deal with China’s top pharma company
Medtech company sues over seven patents for incontinence products
10x Genomics settles suit with rival and targets DNA sequencing startup
From the courtroom: Hikma v Amarin SCOTUS oral arguments
Moderna loses key mRNA patent in European vaccine fight
Ligand buys biotech in $739m cash deal with litigation sweetener